Skip to main content
Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada flag Canada · Delayed Price · Currency is CAD
0.160
-0.005 (-3.03%)
Apr 28, 2026, 3:59 PM EST

Pharmala Biotech Holdings Revenue

Pharmala Biotech Holdings had revenue of 280.58K CAD in the quarter ending February 28, 2026, with 92.63% growth. This brings the company's revenue in the last twelve months to 889.57K, up 106.79% year-over-year. In the fiscal year ending August 31, 2025, Pharmala Biotech Holdings had annual revenue of 605.50K, down -41.51%.

Revenue (ttm)
889.57K
Revenue Growth
+106.79%
P/S Ratio
19.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.42M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2025605.50K-429.80K-41.51%
Aug 31, 20241.04M503.29K94.60%
Aug 31, 2023532.00K453.93K581.44%
Aug 31, 202278.07K--
Aug 31, 2021---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Britannia Life Sciences 157.68K
Rapid Dose Therapeutics 2.78M
Innovotech 4.53M
Glow Lifetech 2.05M
COSCIENS Biopharma 10.28M
Revenue Rankings

Pharmala Biotech Holdings News

More News